$6.89
-0.27[-3.77%]
At close: May 31
$6.89
0[0.00%]
After Hours: 4:48PM EDT
Accolade
(NASDAQ:ACCD)Accolade Stock (NASDAQ:ACCD), Analyst Ratings, Price Targets, Predictions
Accolade Inc has a consensus price target of $18.22, established from looking at the 88 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, Wells Fargo, and Morgan Stanley on May 8, 2024, April 30, 2024, and April 26, 2024. With an average price target of $11.67 between Guggenheim, Wells Fargo, and Morgan Stanley, there's an implied 69.33% upside for Accolade Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Wells Fargo
Morgan Stanley
Truist Securities
Canaccord Genuity
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Accolade
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | Buy Now | 88.68% | Guggenheim | Sandy Draper | $17 → $13 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 45.14% | Wells Fargo | Stan Berenshteyn | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 74.17% | Morgan Stanley | Ricky Goldwasser | $13 → $12 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 103.19% | Truist Securities | Jailendra Singh | $16 → $14 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 132.22% | Canaccord Genuity | Richard Close | $18 → $16 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 59.65% | Barclays | — | $13 → $11 | Maintains | Equal-Weight | Get Alert |
| 04/26/2024 | Buy Now | 88.68% | Needham | Ryan MacDonald | $12 → $13 | Maintains | Buy | Get Alert |
| 04/22/2024 | Buy Now | 88.68% | Stifel | David Grossman | $15 → $13 | Maintains | Buy | Get Alert |
| 02/26/2024 | Buy Now | 132.22% | Leerink Partners | Michael Cherny | → $16 | Initiates | → Outperform | Get Alert |
| 01/19/2024 | Buy Now | 146.73% | Needham | Ryan MacDonald | → $17 | Reiterates | Buy → Buy | Get Alert |
| 01/09/2024 | Buy Now | 132.22% | Raymond James | John Ransom | $12 → $16 | Maintains | Outperform | Get Alert |
| 01/09/2024 | Buy Now | 117.71% | Piper Sandler | Jessica Tassan | $12 → $15 | Maintains | Overweight | Get Alert |
| 01/09/2024 | Buy Now | 132.22% | Truist Securities | Jailendra Singh | $15 → $16 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | 74.17% | Wells Fargo | Stan Berenshteyn | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 01/04/2024 | Buy Now | 117.71% | Stifel | David Grossman | $17 → $15 | Maintains | Buy | Get Alert |
| 11/22/2023 | Buy Now | 74.17% | Piper Sandler | Jessica Tassan | $15 → $12 | Maintains | Overweight | Get Alert |
| 10/05/2023 | Buy Now | 146.73% | Canaccord Genuity | Richard Close | $18 → $17 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | 117.71% | Truist Securities | Jailendra Singh | $17 → $15 | Maintains | Buy | Get Alert |
| 10/05/2023 | Buy Now | 161.25% | Stephens & Co. | Jeff Garro | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 10/05/2023 | Buy Now | 74.17% | Raymond James | John Ransom | $15 → $12 | Maintains | Outperform | Get Alert |
| 10/02/2023 | Buy Now | 146.73% | Truist Securities | Jailendra Singh | → $17 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2023 | Buy Now | 146.73% | Needham | Ryan MacDonald | → $17 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | Buy Now | 161.25% | Stephens & Co. | Jeff Garro | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/03/2023 | Buy Now | 103.19% | Morgan Stanley | Ricky Goldwasser | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 146.73% | Stifel | David Grossman | $15 → $17 | Maintains | Buy | Get Alert |
| 06/30/2023 | Buy Now | 103.19% | Morgan Stanley | Ricky Goldwasser | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 103.19% | Wells Fargo | Stan Berenshteyn | $13 → $14 | Maintains | Equal-Weight | Get Alert |
| 06/30/2023 | Buy Now | 117.71% | Credit Suisse | Jonathan Yong | $13 → $15 | Maintains | Neutral | Get Alert |
| 06/30/2023 | Buy Now | 146.73% | Needham | Ryan MacDonald | $15 → $17 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 117.71% | Needham | Ryan MacDonald | → $15 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Accolade (ACCD)?
The latest price target for Accolade (NASDAQ: ACCD) was reported by Guggenheim on May 8, 2024. The analyst firm set a price target for $13.00 expecting ACCD to rise to within 12 months (a possible 88.68% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Accolade (ACCD)?
The latest analyst rating for Accolade (NASDAQ: ACCD) was provided by Guggenheim, and Accolade maintained their buy rating.
When was the last upgrade for Accolade (ACCD)?
The last upgrade for Accolade Inc happened on May 24, 2023 when B of A Securities raised their price target to $16.5. B of A Securities previously had a neutral for Accolade Inc.
When was the last downgrade for Accolade (ACCD)?
The last downgrade for Accolade Inc happened on February 9, 2023 when Jefferies changed their price target from N/A to $14 for Accolade Inc.
When is the next analyst rating going to be posted or updated for Accolade (ACCD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Accolade, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Accolade was filed on May 8, 2024 so you should expect the next rating to be made available sometime around May 8, 2025.
Is the Analyst Rating Accolade (ACCD) correct?
While ratings are subjective and will change, the latest Accolade (ACCD) rating was a maintained with a price target of $17.00 to $13.00. The current price Accolade (ACCD) is trading at is $6.89, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.